smgt glp-1 ATTDX® SlimBalance SMGT-GLP-1 NanoDart Patches Parche Nano Smgt-glp-1, Suave Firme
Description
How are GLP-1 drugs changing what people eat
First and only anti-CD20 monoclonal antibody proven to deliver renal response benefits in a Phase III trial Twice-yearly dosing and a 90-minute infusion time Offers new hope to the 1.7 million people worldwidemostly women of colour and childbearing age affected by lupus nephritis #Roche #FDAApproval #LupusNephritis #Intellectt #Biopharma #MedicalInnovation #MonoclonalAntibody #DrugDevelopment #ClinicalTrials #Gazyva #HealthcareInnovation #LifeSciences To view or add a comment, sign in 4,021 followers
28 August 2025
[PubMed Central ID: PMC8304478]
Some drugs, such as corticosteroids or certain antipsychotics, can counteract weight loss and glycaemic improvements
